Stability of lyophilized pooled sera as quality control materials for tumor marker assays in external quality assessment.

[1]  J. Costello,et al.  Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation , 2015, Journal of computer assisted tomography.

[2]  Hui Jiang,et al.  Quantum dots based potential-resolution dual-targets electrochemiluminescent immunosensor for subtype of tumor marker and its serological evaluation. , 2015, Analytical chemistry.

[3]  L. Cazares,et al.  Thermal inactivation of enzymes and pathogens in biosamples for MS analysis. , 2015, Bioanalysis.

[4]  V. Bhat,et al.  The External Quality Assessment Scheme (EQAS): Experiences of a medium sized accredited laboratory. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[5]  A. García-de la Torre,et al.  Homocysteine: new tumor marker in pleural fluid , 2015, Tumor Biology.

[6]  M. Husain,et al.  What Is The New Tumor Marker For Detection Of Different Kidney Tumors? Modern Study To Isolation, Purification, And Characterization Of Galactose Binding Lectin From Sera Of Patients With Kidney Cancer , 2015 .

[7]  Ferruccio Ceriotti,et al.  The role of External Quality Assessment Schemes in monitoring and improving the standardization process. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[8]  Y. Inoue,et al.  Serum levels of leptin receptor in patients with malignant melanoma as a new tumor marker , 2013, Experimental dermatology.

[9]  Rixin Jamtsho.  Stability of Lyophilized Human Serum for Use as Quality Control Material in Bhutan , 2013, Indian Journal of Clinical Biochemistry.

[10]  O. Nilsson,et al.  Suitability of quality control materials for prostate-specific antigen (PSA) measurement: inter-method variability of common tumor marker control materials , 2013, Clinical chemistry and laboratory medicine.

[11]  U. Ballehaninna,et al.  The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. , 2012, Journal of gastrointestinal oncology.

[12]  J. Sørensen,et al.  Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. , 2012, Lung cancer.

[13]  Y. Inoue,et al.  The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. , 2011, Journal of dermatological science.

[14]  Yeowon Sohn,et al.  Effects of sugar additives on protein stability of recombinant human serum albumin during lyophilization and storage , 2007, Archives of pharmacal research.

[15]  M. Duffy,et al.  Serum tumor markers in breast cancer: are they of clinical value? , 2006, Clinical chemistry.

[16]  O. Blaabjerg,et al.  Minimally processed fresh frozen human reference sera: preparation, testing, and application to international external quality assurance , 2004, Scandinavian journal of clinical and laboratory investigation.

[17]  P. Dombernowsky,et al.  Interpretation of Sequential Measurements of Cancer Antigen 125 (CA 125), Carcinoembryonic Antigen (CEA) and Tissue Polypeptide Antigen (TPA) Based on Analytical Imprecision and Biological Variation in the Monitoring of Ovarian Cancer , 2001, Clinical chemistry and laboratory medicine.

[18]  A.M.H. van der Veen,et al.  Homogeneity and stability of reference materials , 2001 .

[19]  F. Ceriotti,et al.  Behavior of frozen serum pools and lyophilized sera in an external quality-assessment scheme. , 1995, Clinical chemistry.

[20]  P. Wood,et al.  Preparation and stability of low-cost liquid quality-control serum stabilized with ethanediol. , 1987, Clinical chemistry.

[21]  D. Chia,et al.  Use of four monoclonal antibodies to detect tumor markers , 1986, Cancer.

[22]  R. Barnett,et al.  Long-term stability of a stabilized liquid quality-control serum. , 1981, Clinical chemistry.

[23]  L. Barker,et al.  Transmission of serum hepatitis. , 1970, JAMA.

[24]  Jason D. Wright,et al.  Serum Tumor Marker Use in Patients With Advanced Solid Tumors. , 2016, Journal of oncology practice.

[25]  Shekhar Sharma,et al.  Tumor markers in clinical practice: General principles and guidelines , 2009, Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology.

[26]  J. J. Fleming,et al.  Report of a trial with lyophilised QC sera in the CMCH/ACBI EQAS programmes in India , 2008, Indian Journal of Clinical Biochemistry.

[27]  I. Bakaltcheva,et al.  Freeze-dried whole plasma: evaluating sucrose, trehalose, sorbitol, mannitol and glycine as stabilizers. , 2007, Thrombosis research.

[28]  M. D. Luque de Castro,et al.  Lyophilization: a useful approach to the automation of analytical processes? , 1990, The Journal of automatic chemistry.

[29]  A. Moossa,et al.  Comprehensive textbook of oncology , 1986 .

[30]  D. Aronson,et al.  Measures to inactivate viral contaminants of pooled plasma products. , 1985, Progress in clinical and biological research.

[31]  R. Elin,et al.  Liquid and lyophilized quality-control materials compared for use in continuous-flow analysis. , 1984, Clinical chemistry.